Author/Authors :
Helena Cortez-Pinto، نويسنده , , Amelia Baptista، نويسنده , , Maria Ermelinda Camilo، نويسنده , , Eduardo Bruno de Costa، نويسنده , , Ana Valente، نويسنده , , Miguel Carneiro de Moura، نويسنده ,
Abstract :
The authors describe three cases of tamoxifen-associated steatohepatitis, which resulted from a daily dosage of 20 mg used as the adjuvant treatment of breast carcinoma. Liver tests became normal after discontinuation of tamoxifen.
